Skip to content
healthcare.dev

BUPROPION HYDROCHLORIDE

NDC 68001-520, BUPROPION HYDROCHLORIDE, tablet, extended release, from BluePoint Laboratories.

Product NDC
68001-520
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210497
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-520 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE300 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
68001-520-046800105200430 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-520-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5ccec958-998d-43a1-86fb-eb2b5e697b77
  • NADAC price for package 68001052004

    GET /v1/drugs/nadac/68001052004

Use it

Look up 68001-520 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-520 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-520. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.